Month: December 2020

Can China Become Self-reliant in Semiconductors?

The U.S. added China’s biggest computer chipmaker SMIC to a blacklist of alleged Chinese military companies last week, a move that will further widen the gap between China’s chip technology and the rest of the world.Despite its status as the world’s factory, China has never figured out how to make advanced chips. In recent years, Beijing has been planning a series of sweeping government policies and pouring billions of dollars into the industry to fulfill its chip self-sufficiency goal.So far, under ever-tightening international export controls, however, the country has only found itself mired in some of the most embarrassing industrial failures in its recent history. Most notably, one of the nation’s most high-profile chipmakers was taken over by municipal authorities in its home city of Wuhan, and a Beijing-based chipmaker, the Tsinghua Unigroup, defaulted on a corporate bond.FILE – A Chinese microchip is seen through a microscope set up at the booth for the state-controlled Tsinghua Unigroup project which is driving China’s semiconductor ambitions during the 21st China Beijing International High-tech Expo in Beijing.In this highly internationally integrated industry, experts say, no country can manufacture chips on its own, and China’s efforts to develop its semiconductor sector remains out of reach.Highly globalized chainSemiconductor production is considered one of the most sophisticated manufacturing processes in the world, involving more than 50 disciplines. Billions of transistor structures must be built within a few millimeters.The core equipment used to manufacture computer chips includes lithography machines. A Dutch company called ASML is the only company in the world currently capable of producing high-end extreme ultraviolet lithography machines. Of its 17 core suppliers, though, more than half are from the United States, and the rest are companies located throughout Europe.The company is jointly owned by shareholders from dozens of countries. According to its official website, among the top three major shareholders, two are from the United States and one is from the United Kingdom. Capital Research and Management Co. is the largest shareholder, and the second largest is the BlackRock Group; both are in the U.S. Additionally, Taiwan’s TSMC and South Korea’s Samsung also hold shares in ASML, allowing these two manufacturers to enjoy the priority right to purchase the machine.   In Bid to Rely Less on US, China Firms Stockpile Taiwan Tech HardwareChina wants to become technologically self-reliant in 10 years but needs help for nowWhile ASML may dominate the chipmaking machine market, it is only one part of the long chain in the industry. The lens of its lithography machine is manufactured by Zeiss of Germany, the laser technology is owned by Cymer of the United States, and a French company provides key valves.Jan-Peter Kleinhans, a senior researcher at the Berlin think tank New Responsibility Foundation and director of the Technology and Geopolitics Project, said no country can make chips without foreign companies’ technology. He told VOA in a telephone interview that it took ASML more than two decades to develop their machines, and “they rely themselves on a network of around 5,000 suppliers to build this machine.”Kleinhans said that without the participation of any one of these companies, the entire global semiconductor chain would break.Kobe Goldberg, a researcher at the New American Security Research Center, told VOA that what China is trying to do is to build a totally nationalized supply chain in a highly internationalized industry. “That is much more difficult in an industry like semiconductors since it is so internationally integrated.”John Lee, a senior researcher at the Mercator Institute for China Studies, a think tank in Germany, said several Chinese firms already have the capacity to manufacture or fabricate some semiconductors. But they can easily face a crackdown by the U.S. government since American companies have a very strong dominance in the upstream segment of the supply chain, such as chip design.
 Huawei’s Survival at Stake as US Sanctions LoomStarting Sept. 15, China’s telecom giant Huawei will be cut off from essential supplies of semiconductors and without those chips, Huawei cannot make smartphones or 5G equipment on which its business depends, business analysts say”The dominance of U.S.-origin technology in upstream sectors of the global semiconductor supply chain means that Chinese ICT [information and communications technology] firms across the board are exposed to U.S. export controls, regardless of what happens to SMIC or Huawei as individual companies,” Lee added.Multilateral export controlThe multilateral export control implemented by democratic countries can be traced back to the informal multilateral regime called the Coordinating Committee for Multilateral Export Controls (CoCom).  Established in 1949, the 17-member organization, including the United States, the United Kingdom, Japan, France and Australia, attempted to coordinate controls over the export of strategic materials and technology to communist countries. In 1952, a separate group was established to scrutinize exports to China.US Imposes Curbs on Exports by China’s Top Chipmaker SMICNew Commerce Department requirements mean American suppliers of certain technology products to SMIC must apply for individual licenses before they can exportAlthough CoCom ceased to function on March 31, 1994, the list of prohibited items it formulated was later inherited by another multilateral export agreement, the Wassenaar Arrangement, which was signed in 1996. As many as 42 European, American and Asian countries joined the program, which allows member states to exercise control over their own technology exports, and China is again included in the list of targeted countries.Last December, the group reached an agreement to add chip manufacturing technology to the list of items subject to export controls.  While this revision does not explicitly target China, it points out that export restrictions are targeted at nonmember states, while China, along with Iran and North Korea, are not member states. Some Chinese observers called the jointly implemented move a “collective action” against China by countries that dominate the chip manufacturing supply chain.The Bureau of Industrial Security of the U.S. Commerce Department also announced in October of this year that six emerging technologies would be included in a new export control under the Wassenaar Agreement. All these technologies are directly related to chip manufacturing, including extreme ultraviolet lithography necessary for advanced chip manufacturing.Martijn Rasser, a senior researcher at the Center for New American Security’s Technology and National Security Project, told VOA the world’s liberal democracies have a huge advantage in their network of alliances and partnerships, adding: “It’s something that China just completely lacks, and that’s a big, a big headwind for them.”

your ads here!

At-Home Kits Aim to Close COVID-19 Testing Gap

Getting a COVID test can mean long lines and delayed results. Matt Dibble looks into recent breakthroughs that may have more of us performing a test at home.
Camera: Matt Dibble       Producer: Matt Dibble

your ads here!

White House Threatens FDA Chief’s Job Over Vaccine Approval

White House chief of staff Mark Meadows on Friday pressed Food and Drug Administration chief Stephen Hahn to grant an emergency use authorization for Pfizer’s coronavirus vaccine by the end of the day or face possible firing, two administration officials said.The vaccine produced by Pfizer Inc. and its German partner BioNTech won a critical endorsement Thursday from an FDA panel of outside advisers, and signoff from the agency — which is expected within days — is the next step needed to get the shots to the public.The FDA is not required to follow the guidance of its advisory committees, but often does.Meadows spoke to Hahn by telephone on Friday, according to a senior administration official who was familiar with the conversation but was not authorized to discuss private conversations.Hahn disputed characterizations of his conversation with Meadows.US On Verge of Launching COVID VaccinationsFDA advisory panel voted to recommend approval of vaccine late Thursday The chief of staff also told Hahn his job was in jeopardy if the emergency use authorization was not issued before Saturday, said a second administration official familiar with the conversation.Hahn signaled that he would tell regulators to allow the vaccine to be issued on an emergency basis, the official said.President Donald Trump has been pressing for quick approval for the vaccine and tweeted directly at Hahn earlier Friday, complaining that FDA “is still a big, old, slow turtle.” Trump has publicly bashed the pace of the FDA’s vaccine review process.”Get the dam vaccines out NOW, Dr. Hahn,” Trump tweeted Friday. “Stop playing games and start saving lives.”Hahn issued a statement later Friday.”This is an untrue representation of the phone call with the chief of staff,” Hahn said in the statement. “The FDA was encouraged to continue working expeditiously on Pfizer-BioNTech’s EUA request. FDA is committed to issuing this authorization quickly, as we noted in our statement this morning.”The FDA said earlier Friday that it “will rapidly work” to grant emergency use of the vaccine. 

your ads here!

Pollstar: Pandemic Cost Live Events Industry $30B

Concert trade publication Pollstar says the live events industry’s revenue is off more than $30 billion in 2020 because of the coronavirus pandemic.Pollstar released its year-end report Friday, explaining that the live events industry should have hit a record-setting $12.2 billion this year but instead incurred $9.7 billion in losses. The company added that the projected $30 billion figure in losses includes “unreported events, ancillary revenues, including sponsorships, ticketing, concessions, merch, transportation, restaurants, hotels and other economic activity tied to the live events.” Those losses accounted for more than $8 billion.In March, hundreds of artists announced their current or upcoming tours would need to be postponed or canceled because of the pandemic. While a small number of performers have played drive-in concerts and others have held digital concerts, the majority of artists have not played live in 2020.With just a few months on the road, Elton John’s “Farewell Yellow Brick Road Tour” tops the year’s Top 100 Worldwide Tours list with $87.1 million grossed from November 30 through March 7. John’s tour ranked No. 2 last year with $212 million grossed.Celine Dion came in second this year with $71.2 million, followed by Trans-Siberian Orchestra ($58.2 million), U2 ($52.1 million) and Queen + Adam Lambert ($44.6 million). Post Malone, Eagles, Jonas Brothers, Dead & Company and Andrea Bocelli rounded out the Top 10.”It’s been an extraordinarily difficult year for the events industry, which has been disproportionately impacted by the coronavirus. As painful as it is to chronicle the adversity and loss our industry and many of our colleagues faced, we understand it is a critical undertaking toward facilitating our recovery, which is thankfully on the horizon,” Ray Waddell, president of Oak View Group’s Media & Conferences Division, which oversees Pollstar and VenuesNow, said in a statement Friday.”With vaccines, better testing, new safety and sanitization protocols, smart ticketing and other innovations, the live industry will be ramping up in the coming months, and we’re sure that at this time next year we’ll have a very different story to tell.”

your ads here!

EU Vaccine Agency Victim of Cyber-attack

The head of the European Union’s medical agency confirmed Friday it had been the subject of a cyberattack for the past two weeks but said it will not impact its ongoing evaluation of COVID-19 vaccines.The cyberattack was originally announced Wednesday, with the agency providing few details. During an online meeting with the European Parliament, European Medicines Agency (EMA) executive director, Emer Cooke, said the agency had “launched a full investigation in close cooperation with the law enforcement officials and other relevant entities.”In a brief statement on its website, Pfizer partner BioNTech said it had been informed that some of the documents related to regulatory submission for its COVID-19 vaccine candidate, which has been stored on an EMA server, had been “unlawfully accessed.” The company said it did not believe any personal data of trial participants had been compromised.Cooke said Friday, “We can assure you that the timelines for the evaluation of the COVID-19 vaccines and treatments are not impacted. And the agency as you see today continues to be fully functional.”The Amsterdam–based agency is evaluating the Pfizer-BioNTech’s COVID-19 vaccine already approved by Britain and Canada, as well as the vaccine candidate from Moderna. The agency said it will make a decision on conditional approval at a meeting to be held by December 29, while a decision on Moderna’s version should follow by January 12.Cooke said based on the data for the two vaccines so far, “the safety and efficacy look very promising, and we have not seen the adverse events coming up that would be a concern.”Earlier this week, Cooke said the vaccine developed by Oxford University and AstraZeneca is also being considered but complete data for that vaccine has not yet been submitted. 

your ads here!

WHO Seeks Global Access to Approved Coronavirus Vaccines

The World Health Organization (WHO) says action and money are needed to ensure coronavirus vaccines are available around the world as Western nations approve them.
During Friday’s COVID-19 briefing at WHO headquarters in Geneva, Director-General Tedros Adhanom Ghebreyesus applauded the fact Britain was already vaccinating its citizens and that Canada, the United states and others would not be far behind. He said to have safe and effective vaccines for a virus that was completely unknown a year ago is an “astounding scientific achievement.”
The WHO chief noted it would be an even greater achievement to ensure all countries have equal access to those vaccines. Tedros said the U.N. agency has worked hard over the past year to secure political commitments from world leaders for equal access to vaccines and he said he wants to see those commitments translated into action.  
He said the WHO needs $4.3 billion to procure vaccines for the world’s neediest countries and urged donors to help fill a funding gap.  
The director-general said the organization is working with its partners to ensure developing countries have infrastructure in place to deliver vaccines to their populations. Through its COVAX vaccine cooperative and the 189 countries participating, Tedros said the WHO has secured nearly a billion doses of three potential vaccines.  Americans Await Final Approval of First COVID-19 Vaccine as Deaths Reach Record HighUS Food and Drug Administration widely expected to authorize emergency use after special panel votes to recommend approval   But Tedros said closing the funding gap is crucial to ensuring the entire world is protected.
“We have all seen images of people being vaccinated against COVID-19. We want to see these same images all over the world, and that will be a true sign of solidarity,” he said Friday.

your ads here!

US On Verge of Launching COVID Vaccinations

The United States could be hours away from starting its COVID-19 vaccination program. The U.S. Food and Drug Administration reportedly could authorize on Friday or Saturday the emergency use of a COVID-19 vaccine produced by U.S. drug maker Pfizer and Germany’s BioNTech. An FDA advisory panel voted to recommend approval of the vaccine late Thursday. With the U.S. on the verge of its inoculation program, human rights group Amnesty International’s director of economic and social justice issued a warning.  Steve Cockburn told The New York Times, “Rich countries have clear human rights obligations not only to refrain from actions that could harm access to vaccines elsewhere, but also to cooperate and provide assistance to countries that need it.”Food and Drug Administration building is shown Dec. 10, 2020 in Silver Spring, Md.The Johns Hopkins University Coronavirus Resource Center said early Friday there are 69.7 million worldwide COVID-19 infections, with 1.6 million deaths. The U.S. continues to lead the world in the number of cases with 15.6 million infections, followed by India with 9.7 million and Brazil with 6.7 million. Robert Redfield, the director of the U.S. Centers for Disease Control and Prevention, said for the next two or three months, the virus in the U.S. could kill as many people every day who died during the September 11, 2001, terrorist attack on the U.S. or the Pearl Harbor attack of December 7, 1941. A health care worker at LAC USC Medical Center swabs a person at a drive-through testing center during the coronavirus outbreak, in Los Angeles, California, Dec. 10, 2020.The daily U.S. death toll passed the 3,000 mark for the first time on Wednesday.Elsewhere, Australia has abandoned a massive order for a locally produced COVID-19 vaccine after it was discovered that the vaccine was producing false positive HIV results during a trial. 
And Germany’s interior minister says his country needs to go into a lockdown now to stop the spread of COVID-19. Horst Seehofer told Der Spiegel magazine, “The only chance to regain control of the situation is a lockdown, but this must happen immediately. If we wait until Christmas, we’ll have to struggle with high numbers for months.” 
 

your ads here!

Biden, Harris Jointly Named Time Magazine’s ‘Person of the Year’

Time magazine has jointly named President-elect Joe Biden and Vice President-elect Kamala Harris its 2020 “Person of the Year.”  
Time’s editor-in-chief Edward Felsenthal says Biden and Harris won the honor for “changing the American story, for showing that the forces of empathy are greater than the furies of division, for sharing a vision of healing in a grieving world.”
Felsenthal notes, “Every elected President since FDR has at some point during his term been a Person of the Year, nearly a dozen of those in a presidential election year. This is the first time we have included a Vice President.”
Time’s other Person of the Year candidates were President Donald Trump; frontline health care workers and Dr. Anthony Fauci; and the movement for racial justice.
 
Time named Trump Person of the Year for 2016, the year he won the presidency, writing that Trump had “upended the leadership of both major political parties and effectively shifted the political direction of the international order.”
Also Thursday, Time named the Korean boy band BTS its Entertainer of the Year and named Los Angeles Lakers star LeBron James its Athlete of the Year.

your ads here!

‘A New Beginning’: Relief, Hope as Britain Begins Mass Coronavirus

British health officials are warning that people with a “significant history” of allergic reactions should not receive the new coronavirus vaccine that was rolled out in a mass vaccination program Tuesday, pending investigation of two adverse reactions.  Britian is the first western country to begin the mass vaccinations, as Henry Ridgwell reports from London.Camera: Henry Ridgwell

your ads here!

Australia Abandons COVID-19 Vaccine Trials After False Positive HIV Results

Clinical trials of a COVID-19 vaccine being developed by Australia’s University of Queensland in partnership with biotech company CSL have been abandoned after participants returned false positive HIV test results. The treatment was a key part of Australia’s response to the pandemic, and the government had signed a deal to buy 51 million doses.Vaccines typically take years of painstaking research to develop, but COVID-19 has sent scientists around the world racing to find an effective treatment.The Australian government was no different, but it has announced the sudden termination of clinical trials of a vaccine being developed at the University of Queensland.A small component of the experimental drug was derived from the human immunodeficiency virus, also known as HIV. It is used to give the vaccine stability, helping it to recognize and then neutralize the coronavirus. Some participants recorded false positive HIV test results. Researchers have stressed that the treatments are harmless and do not expose patients to the risk of disease.Biotech giant CSL, which has worked alongside the university team in Queensland, has insisted the vaccine had a “strong safety profile.”Phase one clinical trials involving 216 people began in July. Phases two and three have been canceled.The University of Queensland vaccine was one of four potential coronavirus treatments secured by the Australian government for potential use next year, including the Oxford University-AstraZeneca drug.“At no stage we believed all four of those vaccines would likely get through that process,” said Australian Prime Minister Scott Morrison. “If that had occurred that would have been truly extraordinary based on the process of vaccine development not only in this country but anywhere else. So, that is why we spread our risk. The advice we have received is that the University of Queensland vaccine will not be able to proceed based on the scientific advice and that will no longer feature as part of Australia’s vaccine plan.”Morrison said the decision to end the trial should give “Australians great assurance that we are proceeding carefully” toward a COVID-19 vaccine.But some experts fear it could damage public confidence in the inoculation program.The government has said Australia’s vaccine agreements will be enough to cover the entire population of 25 million people, even if one or two candidates proved unsuccessful.Australia has recorded 28,000 coronavirus cases since the pandemic began, and 908 people have died, according to Johns Hopkins University data.

your ads here!

Americans May Get First Vaccines This Weekend

A US government advisory panel on Thursday recommended emergency use of the Pfizer-BioNTech coronavirus vaccine, which meant Americans could begin being vaccinated as soon as this weekend. Earlier this week, the country recorded its highest death toll from COVID-19, with more than 3,100 deaths in a single day. White House correspondent Patsy Widakuswara has the story.
Producer: Kim Weeks

your ads here!

When and Which COVID-19 Vaccines Are Likely to be Available in Asia

Trial data from Pfizer Inc with partner BioNTech SE, Moderna Inc and AstraZeneca Plc has shown their experimental vaccines are effective in preventing novel coronavirus infection.While regulatory processes are underway, few Asian countries expect to receive significant amounts of the vaccines initially. Here are estimated distribution time lines, supply deals announced and clinical trials being held in the region.AustraliaThe country has secured around 140 million doses: 53.8 million from AstraZeneca, 51 million from Novavax Inc, 10 million from Pfizer, and 25.5 million from distribution program COVAX.It expects delivery of 3.8 million doses of AstraZeneca’s vaccine in January and February next year and plans to begin inoculations in March.ChinaChina has not announced supply deals with Western drug makers, which instead have partnered with private companies in the country.AstraZeneca’s vaccine may be approved in China by mid-2021 and its Chinese partner Shenzhen Kangtai Biological Products Co Ltd plans annual production capacity of at least 100 million doses by the end of this year.For the Pfizer/BioNTech vaccine, a unit of Shanghai Fosun Pharmaceutical Group Co Ltd plans a Phase II trial.Tibet Rhodiola Pharmaceutical Holding Co is bringing in Russian vaccine candidate Sputnik V and plans early and mid-stage trials in China.China has also approved three vaccine candidates developed by Sinovac Biotech Ltd and state-owned China National Pharmaceutical Group (Sinopharm) for emergency use, and Sinopharm hopes its two candidates will get conditional approval for general use this year.JapanJapan has deals to buy 120 million doses from Pfizer/BioNTech in the first half of next year and 120 million from AstraZeneca – the first 30 million of which will be shipped by March 2021 – and 250 million from Novavax.It is also in talks with Johnson & Johnson and has a deal with Shionogi & Co Ltd.Experts said vaccine makers would need to conduct at least Phase I and II trials in Japan before seeking approval for use.South KoreaThe country has deals to buy 20 million doses each from AstraZeneca, Pfizer and Moderna and another 4 million doses from Johnson & Johnson’s Janssen, enough to cover up to 34 million people.It will procure additional doses for 10 million people through COVAX.Inoculation is likely to start in the second quarter of next year to allow time to observe possible side effects.IndiaThe head of the Serum Institute of India, which makes the AstraZeneca vaccine, said on Nov. 23 the positive late-state trial result of the candidate will allow it to seek emergency use approval by year-end, before securing approval for full introduction by February or March.India also expects a government-backed vaccine to be launched as early as February. It is also conducting a late-stage trial of Sputnik V.TaiwanTaiwan aims to secure around 15 million doses initially, both via the COVAX scheme and by direct purchases from manufacturers, and may buy an additional 15 million doses.The government has said it hopes to begin vaccinations in the first quarter next year.MalaysiaThe Southeast Asian nation has agreed to buy 12.8 million doses of the Pfizer vaccine, becoming the first country in the region to announce a deal with the U.S. drug maker after some expressed reservations over the need for the ultra-cold storage that the vaccine requires.Pfizer will deliver the first batch of 1 million doses in the first quarter of next year.The PhilippinesThe archipelago announced a deal on Nov. 27 for 2.6 million doses of the AstraZeneca vaccine and is discussing a possible 1 million more, covering about 1% of a population of 108 million people.It is also seeking 20 million to 50 million doses from Sinovac and is in talks with others, including Pfizer.Vaccine makers can seek approval from Philippine regulators even if no clinical trial is conducted in the country.IndonesiaSoutheast Asia’s most populous country has secured 125.5 million doses from Sinovac, 30 million from Novavax, is in talks with AstraZeneca and Pfizer to buy 50 million doses each, and expects to get 16 million from COVAX.Indonesia is testing Sinovac’s vaccine and preparing mass vaccination for medical staff and other frontline workers to start as soon as late January.VietnamA government official said COVAX vaccines would cover only 20% of the population and the country is likely to have a chance to secure separate deals soon, as demand is very high.BangladeshBangladesh signed a deal with India’s Serum Institute to buy 30 million doses of the AstraZeneca vaccine.It also expects to receive 68 million doses from global vaccine alliance GAVI at a subsidized rate, a senior health ministry official said.

your ads here!

At-Home Test Kits: New Tools to Close the COVID-19 Testing Gap

Getting a COVID test can mean long lines and delayed results. Matt Dibble looks into recent breakthroughs that may have more of us performing a test at home.
Camera: Matt Dibble       Producer: Matt Dibble

your ads here!

Accepting Nobel Peace Prize, UN World Food Program Warns Of ‘Hunger Pandemic’

The United Nations’ World Food Program was awarded the 2020 Nobel Peace Prize in a virtual ceremony Thursday. As Henry Ridgwell reports, the head of the organization warned that hundreds of millions of people are facing starvation around the world, exacerbated by the coronavirus pandemic. 
Camera: Henry Ridgwell   Produced by: Mary Cieslak 
 

your ads here!

FDA Panel Recommends Approval of First COVID-19 Vaccine

After nine hours of deliberation Thursday, a special panel of the U.S. Food and Drug Administration approved for emergency use a coronavirus vaccine developed by U.S. pharmaceutical giant Pfizer and Germany’s BioNTech. The decision was made as the U.S. continues to confirm record numbers of coronavirus cases. As of Thursday evening, the U.S. had recorded 15.5 million cases and more than 291,000 deaths, according to Johns Hopkins University data. Of the 22 people on the special panel of the Food and Drug Administration (FDA), 17 voted yes, four voted no and one abstained on the question: “Based on the totality of scientific evidence available, do the benefits of the Pfizer/BioNTech COVID-19 vaccine outweigh its risks for use in individuals 16 years of age and older?” With the recommendation of the emergency use authorization by the Vaccines and Related Biological Products Advisory Committee, the FDA will likely give its final consent as early as Friday or Saturday. The U.S. government will immediately ship 6.4 million doses of the vaccine across the country, with front-line health care workers receiving top priority for the first inoculations. The U.S. military will also prioritize its health care workers for its initial allocation of the Pfizer/BioNTech vaccine, which will be just less than 44,000 doses.  A Pentagon spokesman told reporters Wednesday that the military will start inoculations “within a day or two” after the FDA approves the emergency use authorization. The vaccinations will be voluntary at first but could become mandatory once the vaccine is fully licensed. Thursday’s meeting was held a day after the United States recorded more than 3,000 COVID-19 deaths in a single day for the first time in the nearly yearlong pandemic.   The Pfizer/BioNTech vaccine has jumped to the front of the line in the global effort to develop a vaccine against the novel coronavirus that causes COVID-19. Britain became the first Western nation to begin mass inoculations of the drug on Tuesday, just days after the government’s medical regulatory agency approved the drug.  VOA’s Richard Green and Esha Sarai contributed to this report.
 

your ads here!

‘Vaccine Nationalism’ Leaves World’s Poorest Nations Unable to Secure COVID-19 Vaccine, UN Chief Says

United Nations Secretary-General Antonio Guterres says “vaccine nationalism” is on the rise as wealthier nations line up to buy millions of doses of potential COVID-19 vaccines at the expense of much poorer nations.During a virtual meeting Wednesday with African Union Commission Chairman Moussa Faki Mahamat, Guterres called for contributions of $4.2 billion over the next two months for the COVID-19 Vaccines Global Access Facility, or COVAX, the joint project between the World Health Organization, the Coalition for Epidemic Preparedness Innovations and Gavi, The Vaccine Alliance, an organization founded by Bill and Melinda Gates to vaccinate children in the world’s poorest countries.     FILE – Canada’s Prime Minister Justin Trudeau attends a news conference in Ottawa, Ontario, Canada, Dec. 7, 2020.Canada approves vaccine
Canada’s national health agency, Health Canada, announced Wednesday it has approved Pfizer-BioNTech’s COVID-19 vaccine, and Canadians will start receiving it as early as next week. Pfizer/BioNTech COVID-19 Vaccine Nears Approval for Emergency Use in USFDA publishes documents online confirming vaccine’s effectivenessIn a statement, Health Canada said that it completed a full independent review of the data on the vaccine’s safety and effectiveness, after receiving the company’s submission October 9. In its statement, the agency said, “Canadians can feel confident that the review process was rigorous and that we have strong monitoring systems in place.” On Monday, Prime Minister Justin Trudeau said that the first doses of the Pfizer vaccine will arrive at 14 Canadian distribution centers next week, with more than 200,000 doses due before the end of the year. Canada has ordered a total of 6 million doses from Pfizer. Canada becomes the third nation, after Britain and Bahrain, to approve the drug for use.The push to approve and purchase the new vaccines comes as many nations are experiencing a mounting toll of new COVID-19 infections and fatalities on a daily basis. The United States, which leads the world with nearly 290,000 deaths out of more than 15.3 million total cases, set a grim milestone Wednesday with more than 3,000 coronavirus deaths, the highest single-day total in the nearly yearlong pandemic.  US sets new record
The U.S. has also averaged well over 200,000 new cases a day over the past seven days, another record-setting figure.  Japan’s health ministry posted 2,810 new COVID-19 cases on Wednesday, it’s highest one-day record since the start of the outbreak, including 555 people across the country diagnosed with serious coronavirus symptoms.  Germany’s national disease control and prevention agency, the Robert Koch Institute, posted 23,679 new coronavirus cases over a 24 hour period on Thursday, it’s highest one-day total.  Thursday’s figure includes 440 deaths, one day after posting 590 fatalities, its highest number of COVID-19 deaths in a single day.The worldwide coronavirus death toll remains at more than 1.5 million people out of more than 68.9 million total infections, according to Johns Hopkins Coronavirus Resource Center.

your ads here!

Washington Art Space Helps Soothe COVID Anxiety

As a way to wrap up 2020, Washington’s Artechouse – the first US museum of digital and experiential art – transformed its space into a unique exhibition designed to help people combat COVID-19 anxiety. Maxim Moskalkov has the story.Camera: Artyom Kokhan, Sergey Sokolov   

your ads here!

NASA Introduces New Crop of Lunar Astronauts

NASA on Wednesday formally introduced 18 astronauts who will take part in the U.S. space agency’s new manned lunar program.Nine men and nine women are the first group of astronauts assigned to the Artemis program, half of whom have already flown into space. Two of the Artemis astronauts, Victor Glover and Kate Rubins, are currently serving on the International Space Station as part of the first full-fledged crew to fly aboard the privately owned SpaceX Crew Dragon.The Artemis astronauts also include Christina Koch and Jessica Meir, who conducted the world’s first all-female spacewalk last year at the ISS.Vice President Mike Pence, who led the introduction ceremony at NASA’s Kennedy Space Center in Florida, hailed the Artemis astronauts as “the future of American space exploration – and that future is bright.”The first Artemis mission, tentatively scheduled for next year, will be an unmanned test flight of NASA’s powerful new Space Launch System and its deep space Orion capsule, which is designed to transport humans to the Moon and Mars.  If NASA achieves its goal of landing the first Artemis crew on the moon in 2024, it will be the first manned lunar mission since the end of the legendary Apollo program in 1972.

your ads here!

US Nearing Approval of First COVID-19 Vaccine

After more than 15.3 million total infections, the United States is on the verge of obtaining a safe and effective COVID-19 vaccine.A special panel of the Food and Drug Administration will meet Thursday morning to consider whether to grant emergency use authorization to the new vaccine developed by U.S.-based pharmaceutical giant Pfizer and Germany’s BioNTech.If the Vaccines and Related Biological Products Advisory Committee recommends the emergency authorization as expected, the FDA will likely give its final consent as early as Friday or Saturday. The federal government will immediately ship 6.4 million doses of the vaccine across the United States, with front-line health care workers receiving top priority for the first inoculations.The U.S. military will also prioritize its health care workers for its initial allocation of the Pfizer/BioNTech vaccine, which will be just under 44,000 doses.  A Pentagon spokesperson told reporters Wednesday that the military will start inoculations “within a day or two” after the FDA approves the emergency use authorization. The vaccinations will be voluntary at first, but could become mandatory once the vaccine is fully licensed.Thursday’s meeting is being held a day after the United States recorded more than 3,000 COVID-19 deaths in a single day for the first time in the nearly yearlong pandemic.The Pfizer/BioNTech vaccine has jumped to the front of the line in the global effort to develop a vaccine against the novel coronavirus that causes COVID-19. Britain became the first Western nation to begin mass inoculations of the drug on Tuesday, just days after the government’s medical regulatory agency approved the drug.

your ads here!

Facebook Faces US Lawsuits That Could Force Sale of Instagram, WhatsApp

The U.S. Federal Trade Commission and nearly every U.S. state sued Facebook Inc. Wednesday, saying it broke antitrust law and should potentially be broken up.With the filing of the twin lawsuits, Facebook becomes the second big tech company to face a major legal challenge this fall.The FTC said in a statement that it would seek an injunction that “could, among other things: require divestitures of assets, including Instagram and WhatsApp.”In its complaint, the coalition of 46 states, Washington, D.C., and Guam also asked for Facebook’s acquisitions of Instagram and WhatsApp to be judged to be illegal.FILE – New York State Attorney General Letitia James listens to a question at a press conference in New York City, Aug. 6, 2020.”For nearly a decade, Facebook has used its dominance and monopoly power to crush smaller rivals, snuff out competition, all at the expense of everyday users,” said New York Attorney General Letitia James.James said the company used vast amounts of money to acquire such rivals before they could threaten the company’s dominance. Facebook said it is reviewing the FTC and state antitrust complaints.The company said the government “now wants a do-over with no regard for the impact that precedent would have on the broader business community or the people who choose our products every day.”The U.S. Justice Department sued Alphabet Inc.’s Google in October, accusing the $1 trillion company of using its market power to fend off rivals.The lawsuits are the biggest antitrust cases in a generation, comparable to the lawsuit against Microsoft Corp. in 1998. The federal government eventually settled that case, but the yearslong court fight and extended antitrust scrutiny prevented the company from thwarting competitors and is credited with clearing the way for the explosive growth of the internet.Facebook shares fell as much as 3% after the news before paring losses and were last down 1.7%. 
 

your ads here!

SpaceX Starship Makes Highest Test Flight, Crashes on Landing

SpaceX launched its shiny, bullet-shaped, straight-out-of-science fiction Starship several miles into the air from a remote corner of Texas on Wednesday, but the 6 1/2-minute test flight ended in an explosive fireball at touchdown.It was the highest and most elaborate flight yet for the rocket ship that Elon Musk says could carry people to Mars in as little as six years.This latest prototype — the first one equipped with a nose cone, body flaps and three engines — was shooting for an altitude of up to 12.5 kilometers. That’s almost 100 times higher than previous hops and skimming the stratosphere.Starship seemed to hit the mark or at least come close. There was no immediate word from SpaceX on how high it went.The full-scale, stainless steel model — 50 meters tall and 9 meters in diameter — soared out over the Gulf of Mexico. After about five minutes, it flipped sideways as planned and descended in a free-fall back to the southeastern tip of Texas near the Mexican border. The Raptor engines reignited for braking and the rocket tilted back upright. Upon touching down, however, the rocket ship became engulfed in flames and ruptured, parts scattering.The entire flight — as dramatic and flashy as it gets, even by SpaceX standards — lasted just over six minutes and 40 seconds. SpaceX broadcast the sunset demo live on its website; repeated delays over the past week and a last-second engine abort Tuesday heightened the excitement among space fans.”Awesome test. Congratulations Starship team!” read a scroll across the screen.Musk kept expectations low going into this first high-altitude attempt by Starship, cautioning earlier this week there was “probably” a 1-in-3 chance of complete success.Two lower, shorter test flights earlier this year from Boca Chica, Texas — a quiet coastal village before SpaceX moved in — used more rudimentary versions of Starship. Essentially cylindrical cans with cone tops and single Raptor engines, these early vehicles reached altitudes of 150 meters. An even earlier model, the short and squat Starhopper, made a tiny, tethered hop in 2019, followed by two increasingly higher climbs.  

your ads here!

WHO: People Living Longer, but With More Disabilities

New global health estimates find people are living six years longer now than 20 years ago, but many more people are living with disabilities that affect their quality of life. The World Health Organization reports life expectancy has gone up from 67 years to 73 years since 2000. Over this period, it notes progress has been made in reducing deaths from a number of communicable diseases.For example, the WHO says HIV/AIDS has dropped from the 8th leading cause of death in 2000 to the 19th in 2019. And tuberculosis, it says, no longer figures among the global top 10 ranked diseases, falling from 7th place to 13th position over the past two decades.   Another big shift since 2000 is that non-communicable diseases have supplanted communicable diseases as the leading causes of death.    FILE – Doctors perform open-heart surgery at a hospital in Bamako, Mali, Sept. 10, 2018.Heart disease remains the world’s number one killer. Samira Asma of WHO’s Division of Data, Analytics and Delivery for Impact says deaths from heart disease have risen by more than two million since 2000, to nearly nine million last year.Neurodegenerative diseases are also taking a big toll.   Alzheimer’s disease and other forms of dementia are ranking among the top 10 causes of death, with 65 percent of those deaths being women.   The report finds death from diabetes has increased by 70 percent, with men most at risk. It says the Eastern Mediterranean is the region most affected, with deaths from diabetes having more than doubled over the past 20 years. The director of WHO’s department of noncommunicable diseases, Bente Mikkelsen, says NCDs remain a huge problem in high-income countries. People there run the risk of illness from tobacco, overuse of alcohol and obesity. However, she says 80 percent of premature death from NCDs now occur in low- and middle-income countries. “When we are unprotected, meaning that we have not been able to modify the risk factors and also the health system is not prepared to respond to heart diseases, diabetes, cancer and lung diseases, we see a very high toll of deaths,” she said.   The report finds disabilities are on the rise, many due to diseases and health conditions.   But it notes injuries are another major cause of disability and death. It reports road traffic injuries have increased by nearly 50% in the African region since 2000 and around 40% in the Eastern Mediterranean. Most of the victims are male. FILE – A policeman passes out leaflets with road accident statistics, in front of a destroyed car which is put on display, during a campaign to promote safe driving in Beirut, April 25, 2007.Drug use in the Americas has emerged as a significant contributor to both disability and death.  Data show there has been a nearly threefold increase in deaths from drug use between 2000 and 2019 in that region. WHO plans to assess the direct and indirect impact of COVID-19 on death and disability in its next edition of Global Health Estimates. 
 

your ads here!